Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amer Sports Inc (AS) vs Biogen Inc (BIIB) Price & Performance

Amer Sports IncTrade
Biogen IncTrade

Price performance (Past 24H)

Key statistics

Amer Sports Inc vs Biogen Inc — how do they compare? Amer Sports Inc trades at $34.1 (market cap $19.69B), while Biogen Inc trades at $204 (market cap $30.13B). The key difference: Biogen Inc is the larger of the two by market cap, and Biogen Inc is trading nearer its 52-week high, Amer Sports Inc nearer its low. Which is the better fit depends on your goals.

ASBIIB
Market Cap
$19.69B$30.13B
Sector
TechnologyHealth
52-Week High
$41.96$216.63
52-Week Low
$29.54$128.93
Enterprise Value
$20.01B$37.20B

Returns comparison

Trailing returns across standard periods

About Amer Sports Inc

Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, and Atomic. It designs and manufactures high-quality equipment, apparel, and footwear for athletes worldwide.

Read more on AS

About Biogen Inc

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.

Read more on BIIB